Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroxyamine SCHEMBL4937262 | 0.69 | ACHE (0.48) | ACHEBCHE | |
| SCHEMBL2058677 | 0.69 | ACHE (0.47) | ACHEBCHE | |
| SCHEMBL1665979 | 0.68 | ACHE (0.46) | ACHEBCHE | |
| SCHEMBL8724092 | 0.68 | ACHE (0.46) | ACHEBCHE | |
| SCHEMBL29752612 | 0.68 | ACHE (0.53) | ACHEBCHE | |
| SCHEMBL3861730 | 0.68 | ACHE (0.46) | ACHEBCHE | |
| SCHEMBL4824142 | 0.68 | ACHE (0.46) | ACHEBCHE | |
| SCHEMBL7111378 | 0.68 | ACHE (0.46) | ACHEBCHE | |
| SCHEMBL307903 | 0.68 | ACHE (0.53) | ACHEBCHE | |
| SCHEMBL5187065 | 0.68 | ACHE (0.46) | ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012041493-A1 | AMINOQUINOLINIUM SALTS, METHODS OF THEIR PRODUCTION AND THEIR USE AS ACTIVE AGENTS FOR BIOTECHNOLOGICAL AND MEDICAL APPLICATIONS AGAINST BINARY TOXINS | JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) | 2012-04-05 | — | — | WO | claimed |
| US-20070060558-A1 | Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents | PALUMED S.A. (FR) | 2007-03-15 | — | — | US | claimed |
| US-20200261340-A1 | CATIONIC DIRECT DYE COMPRISING AN ALIPHATIC CHAIN AND BEARING A DISULFIDE/THIOL/PROTECTED-THIOL FUNCTION FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2020-08-20 | — | — | US | disclosed |
| EP-3373902-B1 | CATIONIC DIRECT DYE COMPRISING AN ALIPHATIC CHAIN AND BEARING A DISULFIDE/THIOL/PROTECTED-THIOL FUNCTION FOR DYEING KERATIN FIBRES | OREAL (FR) | 2020-04-29 | — | — | EP | disclosed |
| EP-3373902-A1 | CATIONIC DIRECT DYE COMPRISING AN ALIPHATIC CHAIN AND BEARING A DISULFIDE/THIOL/PROTECTED-THIOL FUNCTION FOR DYEING KERATIN FIBRES | L'Oréal (FR) | 2018-09-19 | — | — | EP | disclosed |
| WO-2017081314-A1 | CATIONIC DIRECT DYE COMPRISING AN ALIPHATIC CHAIN AND BEARING A DISULFIDE/THIOL/PROTECTED-THIOL FUNCTION FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2017-05-18 | — | — | WO | disclosed |
| WO-2012041493-A1 | AMINOQUINOLINIUM SALTS, METHODS OF THEIR PRODUCTION AND THEIR USE AS ACTIVE AGENTS FOR BIOTECHNOLOGICAL AND MEDICAL APPLICATIONS AGAINST BINARY TOXINS | JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) | 2012-04-05 | — | — | WO | disclosed |
| US-20090307791-A1 | CALCIUM-ACTIVATED CHLORIDE CHANNEL AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-12-10 | — | — | US | disclosed |
| US-7553477-B2 | Zeolitic microporous crystalline material with an LTA structure (ITQ-29), preparation method thereof and uses of same in organic compound separation and transformation processes | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2009-06-30 | — | — | US | disclosed |
| US-20070098629-A1 | Zeolitic microporous crystalline material with an LTA structure (ITQ-29), preparation method thereof and uses of same in organic compound separation and transformation processes | UNIVERSIDAD POLITECNICA DE VALENCIA (ES) | 2007-05-03 | — | — | US | disclosed |
| US-20070060558-A1 | Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents | PALUMED S.A. (FR) | 2007-03-15 | — | — | US | disclosed |
| EP-1736441-A1 | ZEOLITIC MICROPOROUS CRYSTALLINE MATERIAL WITH AN LTA STRUCTURE (ITQ-29), PREPARATION METHOD THEREOF AND USES OF SAME IN ORGANIC COMPOUND SEPARATION AND TRANSFORMATION PROCESSES | Consejo Superior de Investigaciones Cientificas (ES) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200261340-A1 | CATIONIC DIRECT DYE COMPRISING AN ALIPHATIC CHAIN AND BEARING A DISULFIDE/THIOL/PROTECTED-THIOL FUNCTION FOR DYEING KERATIN FIBRES | KRT18, TST, PDIA5 | ACHE 3104/4885BCHE 4370/4885 |
| US-20070060558-A1 | Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents | QARS1, QPCT, QTRT2 | ACHE 2296/4885BCHE 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.